Skip to main content
Back
Watch Compare

RESMED INC

Data quality: 100%
RSMDF
NYSE Manufacturing Measuring & Analyzing Instruments
$19.66
$0.00 (0.00%)
Mkt Cap: 28.64 B
Price
$19.66
Mkt Cap
28.64 B
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 12.64% annually over 5 years — strong growth
Earnings grew 37.20% over the past year
ROE of 23.88% indicates high profitability
Net margin of 27.53% shows strong profitability
Debt/Equity of 0.11 — conservative balance sheet
Generating 1.79 B in free cash flow

Growth

Revenue Growth (5Y)
12.64%
Above sector avg (1.82%)
Revenue (1Y)9.84%
Earnings (1Y)37.20%
FCF Growth (3Y)70.20%

Quality

Return on Equity
23.88%
Above sector avg (-53.41%)
ROIC20.05%
Net Margin27.53%
Op. Margin33.70%

Safety

Debt / Equity
0.11
Below sector avg (0.31)
Current Ratio3.06
Interest CoverageN/A

Valuation

PE (TTM)
19.28
Above sector avg (-1.48)
P/B Ratio4.53
EV/EBITDA13.78
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 19.3 -1.5
P/B 4.5 1.6
ROE % 23.9 -53.4
Net Margin % 27.5 -41.5
Rev Growth 5Y % 12.6 1.8
D/E 0.1 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 9.84% Revenue Growth (3Y) 10.39%
Earnings Growth (1Y) 37.20% Earnings Growth (3Y) 24.92%
Revenue Growth (5Y) 12.64% Earnings Growth (5Y) 31.08%
Profitability
Revenue (TTM) 5.40 B Net Income (TTM) 1.49 B
ROE 23.88% ROA 17.68%
Gross Margin 60.87% Operating Margin 33.70%
Net Margin 27.53% Free Cash Flow (TTM) 1.79 B
ROIC 20.05% FCF Growth (3Y) 70.20%
Safety
Debt / Equity 0.11 Current Ratio 3.06
Interest Coverage N/A Asset Turnover 0.64
Working Capital 2.57 B Tangible Book Value 2.85 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 19.28 Forward P/E N/A
P/B Ratio 4.53 P/S Ratio 5.31
PEG Ratio 0.62 Forward PEG N/A
EV/EBITDA 13.78 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 6.26%
Market Cap 28.64 B Enterprise Value 27.89 B
Per Share
EPS (Diluted TTM) 10.11 Revenue / Share 3.71
FCF / Share 1.23 OCF / Share 1.31
EPS CAGR (1Y) 37.43% EPS CAGR (5Y) 30.89%
EPS CAGR (10Y) 16.06%
Efficiency
CapEx / Revenue 2.28% FCF Conversion 120.58%
SBC-Adj. FCF 1.70 B Growth Momentum -2.80

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.15 B 4.69 B 4.22 B 3.58 B 3.20 B
Net Income 1.40 B 1.02 B 897.56 M 779.44 M 474.51 M
EPS (Diluted) 9.51 6.92 6.09 5.30 3.24
Gross Profit 3.05 B 2.66 B 2.36 B 2.02 B 1.84 B
Operating Income 1.69 B 1.32 B 1.13 B 1.00 B 903.68 M
EBITDA — — — — —
R&D Expenses 331.28 M 307.53 M 287.64 M 253.58 M 225.28 M
SG&A Expenses 991.02 M 917.14 M 874.00 M 739.37 M 670.39 M
D&A 198.47 M 176.87 M 165.16 M 159.61 M 156.76 M
Interest Expense — — -47.38 M -22.31 M 23.99 M
Income Tax 276.84 M 243.85 M 204.11 M 181.05 M 409.16 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.17 B 6.87 B 6.75 B 5.10 B 4.73 B
Total Liabilities 2.21 B 2.01 B 2.62 B 1.74 B 1.84 B
Shareholders' Equity 5.97 B 4.86 B 4.13 B 3.36 B 2.89 B
Total Debt 668.29 M 707.21 M 1.44 B 775.24 M 655.35 M
Cash & Equivalents 1.21 B 238.36 M 227.89 M 273.71 M 295.28 M
Current Assets 3.51 B 2.36 B 2.37 B 1.93 B 1.57 B
Current Liabilities 1.02 B 910.66 M 758.53 M 689.30 M 911.77 M